Patients with rheumatoid arthritis have an altered circulatory aggrecan profile. - Wikidata - awgldk - TriplyDB

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

http://www.wikidata.org/entity/Q33338239

about

Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Comparison of differential biomarkers of osteoarthritis with and without posttraumatic injury in the Hartley guinea pig model.Matrix metalloproteinase-dependent turnover of cartilage, synovial membrane, and connective tissue is elevated in rats with collagen induced arthritis.Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study.Application of biochemical markers in development of drugs for treatment of osteoarthritis.Mesenchymal Stem Cell-Conditioned Medium Reduces Disease Severity and Immune Responses in Inflammatory Arthritis.

P2860

Q27687777-9CC11097-1A6B-4C40-8090-B1CA36436C69 Q33872728-31A5B97F-CEBC-4E5C-BD8D-C6B88FCF8D4D Q36552653-CF62C186-E57E-4D83-884B-61E7EF3E0477 Q37270865-BBCB5FC3-0EAA-4790-940C-DD28CB541B57 Q37677789-4E533B13-EDE7-49F0-9E39-8FD868891B71 Q47171663-5868AD21-7FCD-4BAC-920E-7BAEFE8A8066

P2860

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

http://www.wikidata.org/entity/Q33338239

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

@ast

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

@en

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

@nl

type

label

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

@ast

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

@en

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

@nl

prefLabel

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

@ast

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

@en

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

@nl

P1433

Q33338239-4039C31E-2A9A-42BD-82A9-FD410470F265

P1476

Q33338239-FEE53480-8625-4FE0-9992-E6CEB2D96B32

P2093

Q33338239-123BF1C3-55C5-4354-9EBB-73B9FE22F4A2

Q33338239-22B89B64-6DE4-4414-AB34-773406EAC5AF

Q33338239-27A024E9-C51F-4453-8AB3-C3A3366B1700

Q33338239-3380F660-82FF-4A7D-9159-30247F875BE5

Q33338239-5B91650E-F257-4EA1-B58D-075C160969C5

Q33338239-75E0950A-516F-4345-8CF5-96AE0CC719AC

Q33338239-8159FEDF-B6FC-4DA0-A504-B947EC1A9843

Q33338239-8ADA4A2E-C94A-4432-8C1A-A185BDB4FA97

Q33338239-D59C113D-3904-4D55-B631-786A62813E69

Q33338239-D98D098E-C42B-481F-A68B-CCD8D4E7A7AF

P2860

Q33338239-0F55072E-DA33-4567-A151-8BFC4F339E4A

Q33338239-190A8501-C862-467E-887C-53D65FBE7F9A

Q33338239-2092032D-B6B9-4CD7-B3C8-12D63DD38579

Q33338239-21DC1A18-3DA8-4B14-9599-A214EB6B6034

Q33338239-25DAB1EB-C991-43AC-937A-86F22F67C11F

Q33338239-5AF49512-551C-46DF-A723-5C38FFC5AF97

Q33338239-5F351679-2BFB-4D4B-88F2-8E0F80EEAD46

Q33338239-6858E57C-1B74-424B-891B-5693A2CD0690

Q33338239-6A9634BD-8D52-400D-8C30-653CABE63433

Q33338239-766D70D8-532C-4CB0-A6A2-3E7F48F36495

P2888

Q33338239-CE641CB8-3FED-4D27-B657-18EEF27D5242

P304

Q33338239-9B94FB2F-AD54-4F14-A9D2-565AB1079801

P31

Q33338239-702C5850-AEE0-41A9-B9D3-4E22524AFDAE

P356

Q33338239-BEF07293-D890-4DE3-BEB3-3768B6DD0BAE

P478

Q33338239-F9E3FD38-A8AB-42E0-BE02-2B9283FF7D60

P577

Q33338239-AC907013-1EA3-4FD9-9AAB-216B43DF747F

P5875

Q33338239-64DCD254-43E4-4AD5-8323-FF7708E556E2

P6179

Q33338239-5C6E52C2-C4D2-4B93-BA92-366688E7DCAD

P698

Q33338239-8D24E279-95F8-4868-B4C6-035B87C4BD09

P932

Q33338239-39A8116F-412D-483D-B2EB-C705234CBAD7

P356

P1433

BMC Musculoskeletal Disorders

P1476

Patients with rheumatoid arthritis have an altered circulatory aggrecan profile.

@en

P2093

Andreas Mueller

http://www.w3.org/2001/XMLSchema#string

Bodil C Sondergaard

http://www.w3.org/2001/XMLSchema#string

Christian Pedersen

http://www.w3.org/2001/XMLSchema#string

Eren U Sumer

http://www.w3.org/2001/XMLSchema#string

Gert Hein

http://www.w3.org/2001/XMLSchema#string

Jean C Rousseau

http://www.w3.org/2001/XMLSchema#string

Morten A Karsdal

http://www.w3.org/2001/XMLSchema#string

Per Qvist

http://www.w3.org/2001/XMLSchema#string

Pierre Delmas

http://www.w3.org/2001/XMLSchema#string

Suzi H Madsen

http://www.w3.org/2001/XMLSchema#string

P2860

The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain

Evolving concepts of rheumatoid arthritis

Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.

Towards a molecular understanding of arthritis.

The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models.

Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases.

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

Structure and function of aggrecan.

Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.

Anti-cyclic citrullinated peptide autoantibodies measured by an automated enzyme immunoassay: analytical performance and clinical correlations.

P2888

P304

74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2474-9-74

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5342779

http://www.w3.org/2001/XMLSchema#string

P6179

1018588960

http://www.w3.org/2001/XMLSchema#string

P698

18507823

http://www.w3.org/2001/XMLSchema#string

P932

2426686

http://www.w3.org/2001/XMLSchema#string